169 related articles for article (PubMed ID: 17178475)
1. Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease.
O'Neill MJ; Messenger MJ; Lakics V; Murray TK; Karran EH; Szekeres PG; Nisenbaum ES; Merchant KM
Int Rev Neurobiol; 2007; 77():179-217. PubMed ID: 17178475
[No Abstract] [Full Text] [Related]
2. [Parkinson's disease: dealing with all dimensions of the disease].
Fénelon G
Rev Prat; 2005 Apr; 55(7):714-6. PubMed ID: 15966413
[No Abstract] [Full Text] [Related]
3. Emerging restorative treatments for Parkinson's disease.
Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection for Parkinson's disease: prospects and promises.
Olanow CW; Schapira AH; Agid Y
Ann Neurol; 2003; 53 Suppl 3():S1-2. PubMed ID: 12666093
[No Abstract] [Full Text] [Related]
5. Neurotrophic factors and Parkinson's disease: the emergence of a new player?
Dauer W
Sci STKE; 2007 Nov; 2007(411):pe60. PubMed ID: 17986711
[TBL] [Abstract][Full Text] [Related]
6. [Glial cell line-derived neurotrophic factor for the rescue of dopaminergic neurons in Parkinson's disease].
Honma Y; Kohsaka S
No To Shinkei; 2003 Oct; 55(10):847-53. PubMed ID: 14635513
[No Abstract] [Full Text] [Related]
7. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
Falk T; Zhang S; Sherman SJ
Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease.
Bradford HF; Zhou J; Pliego-Rivero B; Stern GM; Jauniaux E
Adv Neurol; 1999; 80():19-25. PubMed ID: 10410698
[No Abstract] [Full Text] [Related]
9. Parkinson's disease and related disorders--XVIII WFN World Congress.
Grosset D
IDrugs; 2010 Feb; 13(2):82-4. PubMed ID: 20127558
[TBL] [Abstract][Full Text] [Related]
10. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
Kordower JH; Isacson O; Leventhal L; Emerich DF
Prog Brain Res; 2000; 127():414-30. PubMed ID: 11142039
[No Abstract] [Full Text] [Related]
11. Localized striatal delivery of GDNF as a treatment for Parkinson disease.
Kirik D; Georgievska B; Björklund A
Nat Neurosci; 2004 Feb; 7(2):105-10. PubMed ID: 14747832
[No Abstract] [Full Text] [Related]
12. [Neuronal death and growth factors: new therapeutic approaches in Parkinson's disease].
Wider C; Burkhard PR; Sajadi A; Vingerhoets FJ
Rev Med Suisse; 2006 May; 2(64):1158-62. PubMed ID: 16734187
[TBL] [Abstract][Full Text] [Related]
13. New treatment improves symptoms of Parkinson's disease.
Mayor S
BMJ; 2002 Apr; 324(7344):997. PubMed ID: 11976237
[No Abstract] [Full Text] [Related]
14. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease.
Bjarkam CR; Sørensen JC
Biol Psychiatry; 2004 Aug; 56(4):213-6. PubMed ID: 15312807
[TBL] [Abstract][Full Text] [Related]
15. Micro- and nanotechnology approaches to improve Parkinson's disease therapy.
Torres-Ortega PV; Saludas L; Hanafy AS; Garbayo E; Blanco-Prieto MJ
J Control Release; 2019 Feb; 295():201-213. PubMed ID: 30579984
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophic factors in the therapy of Parkinson's disease.
Facchinetti F; Terrazzino S; D'Arrigo A; Rinaldi L; Leon A
Funct Neurol; 2001; 16(1):45-56. PubMed ID: 11396271
[No Abstract] [Full Text] [Related]
17. Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
Lindvall O; Wahlberg LU
Exp Neurol; 2008 Jan; 209(1):82-8. PubMed ID: 17963752
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
[TBL] [Abstract][Full Text] [Related]
19. Preclinical development of gene therapy for Parkinson's disease.
Porras G; Bezard E
Exp Neurol; 2008 Jan; 209(1):72-81. PubMed ID: 17904121
[TBL] [Abstract][Full Text] [Related]
20. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
